About: Impact of COVID‐19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of COVID‐19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Impact of COVID‐19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR)
Creator	Belli, Luca Polak, Wojciech Adam, Rene Baumann, Ulrich Duvoux, Christophe Fondevila, Constantino Germani, Giacomo Karam, Vincent Nadalin, Silvio Taimr, Pavel Toso, Christian Troisi, Roberto Zieniewicz, Krzysztof
Source	Medline; PMC
abstract	There are scarce data on the impact of COVID‐19 pandemic on liver transplantation (LT) in Europe. The aim of this study was to obtain a preliminary data on incidence, management and outcome of COVID‐19 in liver transplant recipients and candidates in Europe. An internet‐based survey was sent to the centers affiliated with ELTR. 109 out of 149 (73%) of ELTR centers located in 28 European countries (93%) responded. 94 (86%) of the centers tested all donors and 75 (69%) centers tested all LT recipients for SARS‐Cov‐2. 73 (67%) centers selected recipients for LT in the COVID‐19 pandemic, whereas 33% did not. Eighty‐eight centers reported COVID‐19 infection in 57 LT candidates and in 272 LT recipients. Overall crude incidence of COVID‐19 among LT candidates and recipients was estimated 1.05 % (range 0.5%‐20% and 0.34% (range 0.1%‐4.8%), respectively and it was significantly higher among candidates (p<0.001). Crude rate of death was 18% (10/57) among candidates and 15% (36/244) among recipients. This first large‐scale European snapshot study clearly shows that both LT candidates and recipients are at a high risk for COVID‐19. These results plead for an early and pro‐active screening of COVID‐19 symptoms in these populations.
has issue date	2020-07-01(xsd:dateTime)
bibo:doi	10.1111/tri.13680
bibo:pmid	32609908
has license	no-cc
sha1sum (hex)	a87f28993fba12ced198b565fb7e9989a1372a94
schema:url	https://doi.org/10.1111/tri.13680
resource representing a document's title	Impact of COVID‐19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR)
has PubMed Central identifier	PMC7361228
has PubMed identifier	32609908
schema:publication	Transpl Int
resource representing a document's body	covid:a87f28993fba12ced198b565fb7e9989a1372a94#body_text
is schema:about of	named entity 'incidence' named entity 'There' named entity 'Transplant' named entity 'European' named entity 'Alert' named entity 'Registry' named entity 'COVID-19' named entity 'liver transplantation' named entity 'study' named entity 'Transplantation' named entity 'liver transplantation' named entity 'Europe' named entity 'Intestine' named entity 'European' named entity 'Europe' named entity 'COVID 19' named entity 'general population' named entity 'disease pattern' named entity 'thoracic' named entity 'CT scan' named entity 'SARS-Cov-2' named entity 'COVID-19 infection' named entity 'SARS-Cov-2' named entity 'intensive care' named entity 'COVID-19' named entity 'immunosuppression' named entity 'COVID-19' named entity 'clinical symptoms' named entity 'COVID-19' named entity 'COVID-19 infection' named entity 'SurveyMonkey' named entity 'SARS-Cov-2' named entity 'SARS-Cov-2' named entity 'operating room' named entity 'empiric' named entity 'epidemic' named entity 'liver' named entity 'PCR' named entity 'prognosis' named entity 'immunosuppression' named entity 'COVID-19 infection' named entity 'Evolution' named entity 'COVID-19 infection' named entity 'death rates' named entity 'COVID-19' named entity 'general population' named entity 'lung' named entity 'COVID-19' named entity 'COVID-19' named entity 'liver transplant' named entity 'Mortality rates' named entity 'questionnaire' named entity 'PCR' named entity 'liver transplant' named entity 'risk factors' named entity 'clinical presentation' named entity 'liver' named entity 'immunosuppression' named entity 'COVID-19 infection' named entity 'study population' named entity 'P-value' named entity 'COVID-19 pandemic' named entity 'co-morbidities' named entity 'COVID-19' named entity 'Lombardy' named entity 'general population' named entity 'COVID-19' named entity 'inflammatory immune response' named entity 'rate of death'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software